The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
A first-in-human phase 0 clinical study of RNA interference–based spherical nucleic acids in patients with recurrent glioblastoma
Open accessAbstract
RNA interference–based spherical nucleic acid nanoconjugates are a potentially safe and brain-penetrant approach for glioblastoma treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
A DNA-based method for rationally assembling nanoparticles into macroscopic materials
Mirkin, C. A., Letsinger, R. L., Mucic, R. C., & Storhoff, J. J. (1996) · Nature · doi:10.1038/382607a0 · Cited by 6,683
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationPhysiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Stupp, R., Taillibert, S., Kanner, A., Read, W., Steinberg, D. M., Lhermitte, B., Toms, S., Idbaih, A., Ahluwalia, M. S., Fink, K., et al. (2017) · JAMA · doi:10.1001/jama.2017.18718 · Cited by 2,644
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
Davis, M. E., Zuckerman, J. E., Choi, C. H. J., Seligson, D., Tolcher, A., Alabi, C. A., Yen, Y., Heidel, J. D., & Ribas, A. (2010) · Nature · doi:10.1038/nature08956 · Cited by 2,505
Self-citationBevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
Oligonucleotide-Modified Gold Nanoparticles for Intracellular Gene Regulation
Rosi, N. L., Giljohann, D. A., Thaxton, C. S., Lytton-Jean, A. K. R., Han, M. S., & Mirkin, C. A. (2006) · Science · doi:10.1126/science.1125559 · Cited by 1,988
Brem, H., Piantadosi, S., Burger, P. C., Walker, M., Selker, R., Vick, N. A., Black, K., Sisti, M., Brem, S., Mohr, G., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)90755-6 · Cited by 1,389
Cutler, J. I., Auyeung, E., & Mirkin, C. A. (2012) · Journal of the American Chemical Society · doi:10.1021/ja209351u · Cited by 1,119
Lomustine and Bevacizumab in Progressive Glioblastoma
Wick, W., Gorlia, T., Bendszus, M., Taphoorn, M., Sahm, F., Harting, I., Brandes, A. A., Taal, W., Domont, J., Idbaih, A., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1707358 · Cited by 970
Coactivation of receptor tyrosine kinases affects the response of tumor cells to targeted therapies
Stommel, J. M., Kimmelman, A. C., Ying, H., Nabioullin, R., Ponugoti, A. H., Wiedemeyer, R., Stegh, A. H., Bradner, J. E., Ligon, K. L., Brennan, C., et al. (2007) · Science · doi:10.1126/science.1142946 · Cited by 938 · cited 1×
“Pathway compensation, such as that demonstrated for members of the receptor tyrosine kinase family (10, 11), suggests that coinhibition strategies are required to improve treatment 1Ken and Ruth Davee Department of Neurology, The Northwestern Malnati Brain Tumor Institute, Feinberg School of Medicine, The Robert H.”
BackgroundSelf-citationEvidence for bulk flow of brain interstitial fluid: significance for physiology and pathology
Abbott, N. J. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.11.006 · Cited by 786
Cutler, J. I., Auyeung, E., & Mirkin, C. A. (2020) · Spherical Nucleic Acids · doi:10.1201/9781003056676-5 · Cited by 676
FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme
Cohen, M. H., Shen, Y. L., Keegan, P., & Pazdur, R. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0121 · Cited by 655
Stupp, R., Taillibert, S., Kanner, A. A., Read, W. L., Steinberg, D. M., Lhermitte, B., Toms, S. A., Idbaïh, A., Ahluwalia, M. S., Fink, K., et al. (2017) · Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) · doi:10.5167/uzh-143757 · Cited by 630
Spherical Nucleic Acid Nanoparticle Conjugates as an RNAi-Based Therapy for Glioblastoma
Jensen, S. A., Day, E. S., Ko, C. H., Hurley, L. A., Luciano, J. P., Kouri, F. M., Merkel, T. J., Luthi, A. J., Patel, P. C., Cutler, J. I., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006839 · Cited by 592
Self-citationBartlett, D. W. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj439 · Cited by 592
Longitudinal molecular trajectories of diffuse glioma in adults
Barthel, F. P., Johnson, K. C., Varn, F. S., Moskalik, A. D., Tanner, G., Kocakavuk, E., Anderson, K. J., Abiola, O., Aldape, K., Alfaro, K. D., et al. (2019) · Nature · doi:10.1038/s41586-019-1775-1 · Cited by 561
Self-citationMechanism for the endocytosis of spherical nucleic acid nanoparticle conjugates
Choi, C. H. J., Hao, L., Narayan, S. P., Auyeung, E., & Mirkin, C. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305804110 · Cited by 533
Silver Nanoparticle−Oligonucleotide Conjugates Based on DNA with Triple Cyclic Disulfide Moieties
Lee, J.-S., Lytton-Jean, A. K. R., Hurst, S. J., & Mirkin, C. A. (2007) · Nano Letters · doi:10.1021/nl071108g · Cited by 500
Nucleic Acid–Metal Organic Framework (MOF) Nanoparticle Conjugates
Morris, W., Briley, W. E., Auyeung, E., Cabezas, M. D., & Mirkin, C. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja503215w · Cited by 478
Glioblastoma targeted therapy: updated approaches from recent biological insights
Touat, M., Idbaih, A., Sanson, M., & Ligon, K. L. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx106 · Cited by 441
Zuckerman, J. E., Gritli, I., Tolcher, A., Heidel, J. D., Lim, D., Morgan, R., Chmielowski, B., Ribas, A., Davis, M. E., & Yen, Y. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1411393111 · Cited by 427
Self-citationClinical experiences with systemically administered siRNA-based therapeutics in cancer
Zuckerman, J. E., & Davis, M. E. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4685 · Cited by 424
Huang, P. H., Mukasa, A., Bonavia, R., Flynn, R. A., Brewer, Z. E., Cavenee, W. K., Furnari, F. B., & White, F. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705158104 · Cited by 390
A general approach to DNA-programmable atom equivalents
Zhang, C., Macfarlane, R. J., Young, K. L., Choi, C. H. J., Hao, L., Auyeung, E., Liu, G., Zhou, X., & Mirkin, C. A. (2013) · Nature Materials · doi:10.1038/nmat3647 · Cited by 317
MAPS : A set of software tools for analysis and visualization of 3D X-ray fluorescence data sets
Vogt, S. (2003) · Journal de Physique IV (Proceedings) · doi:10.1051/jp4:20030160 · Cited by 298
Iron as a central player and promising target in cancer progression
Jung, M., Mertens, C., Tomat, E., & Brüne, B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020273 · Cited by 268 · cited 1×
“The majority of Au was found associated with the Zn-rich vasculature (XFM maps of RBCs show particularly high Zn, although this element is also found in leukocytes and plasma), as well as in Fe-positive cells, in particular tumor-associated macrophages, which represent a critical source of Fe within the tumor microenv…”
BackgroundSchultheis, B., Strumberg, D., Santel, A., Vank, C., Gebhardt, F., Keil, O., Lange, C., Giese, K., Kaufmann, J., Khan, M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.55.0376 · Cited by 260
Mackic, J. B., Stins, M., McComb, J. G., Calero, M., Ghiso, J., Kim, K. S., Yan, S. D., Stern, D., Schmidt, A. M., Frangione, B., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2029 · Cited by 242
miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma
Kouri, F. M., Hurley, L. A., Daniel, W. L., Day, E. S., Hua, Y., Hao, L., Peng, C.-Y., Merkel, T. J., Queisser, M. A., Ritner, C., et al. (2015) · Genes & Development · doi:10.1101/gad.257394.114 · Cited by 220
Self-citationPearson, A. M., Rich, A., & Krieger, M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53729-7 · Cited by 215
Liposomal Spherical Nucleic Acids
Banga, R. J., Chernyak, N., Narayan, S. P., Nguyen, S. T., & Mirkin, C. A. (2014) · Journal of the American Chemical Society · doi:10.1021/ja504845f · Cited by 210
Polyvalent Nucleic Acid Nanostructures
Cutler, J. I., Zhang, K., Zheng, D., Auyeung, E., Prigodich, A. E., & Mirkin, C. A. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203375n · Cited by 180
Goti, D., Hrzenjak, A., Levak‐Frank, S., Frank, S., van der Westhuyzen, D. R., Malle, E., & Sattler, W. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00100.x · Cited by 169
Polyvalent Oligonucleotide Iron Oxide Nanoparticle “Click” Conjugates
Cutler, J. I., Zheng, D., Xu, X., Giljohann, D. A., & Mirkin, C. A. (2010) · Nano Letters · doi:10.1021/nl100477m · Cited by 161
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastomaPreprint
Stegh, A. H., Kim, H., Bachoo, R. M., Forloney, K. L., Zhang, J., Schulze, H., Park, K. K., Hannon, G. J., Yuan, J., Louis, D. N., et al. (2007) · Genes & Development · doi:10.1101/gad.1480007 · Cited by 155
Self-citationStrumberg, D., Schultheis, B. S., Traugott, U., Vank, C., Santel, A., Keil, O., Giese, K., Kaufmann, J., & Drevs, J. (2011) · International Journal of Clinical Pharmacology and Therapeutics · doi:10.5414/cpp50076 · Cited by 149
Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Stupp, R., & Roila, F. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp151 · Cited by 148
Stegh, A. H., Kesari, S., Mahoney, J. E., Jenq, H. T., Forloney, K. L., Protopopov, A. I., Louis, D. N., Chin, L., & DePinho, R. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712034105 · Cited by 144
Self-citationCellular Response of Polyvalent Oligonucleotide−Gold Nanoparticle Conjugates
Massich, M. D., Giljohann, D. A., Schmucker, A. L., Patel, P. C., & Mirkin, C. A. (2010) · ACS Nano · doi:10.1021/nn102228s · Cited by 139
Young, K. L., Scott, A. W., Hao, L., Mirkin, S. E., Liu, G., & Mirkin, C. A. (2012) · Nano Letters · doi:10.1021/nl3020846 · Cited by 128
Impact of bevacizumab chemotherapy on craniotomy wound healing
Clark, A. J., Butowski, N. A., Chang, S. M., Prados, M. D., Clarke, J. L., Polley, M. C., Sughrue, M. E., McDermott, M. W., Parsa, A. T., Berger, M. S., et al. (2010) · Journal of neurosurgery · doi:10.3171/2010.10.jns101042 · Cited by 105
Scorilas, A., Kyriakopoulou, L. G., Yousef, G. M., Ashworth, L. K., Kwamie, A., & Diamandis, E. P. (2001) · Genomics · doi:10.1006/geno.2000.6455 · Cited by 101
Probing the inherent stability of siRNA immobilized on nanoparticle constructs
Barnaby, S. N., Lee, A., & Mirkin, C. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409431111 · Cited by 97
Glioma oncoprotein Bcl2L12 inhibits the p53 tumor suppressor
Stegh, A. H., Brennan, C., Mahoney, J. E., Forloney, K. L., Jenq, H. T., Luciano, J. P., Protopopov, A. I., Chin, L., & DePinho, R. A. (2010) · Genes & Development · doi:10.1101/gad.1924710 · Cited by 94
Self-citationBeyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma
Stegh, A. H., & DePinho, R. A. (2011) · Cell Cycle · doi:10.4161/cc.10.1.14365 · Cited by 73
Self-citationCalabrese, C. M., Merkel, T. J., Briley, W. E., Randeria, P. S., Narayan, S. P., Rouge, J. L., Walker, D., Scott, A. W., & Mirkin, C. A. (2014) · Angewandte Chemie International Edition · doi:10.1002/anie.201407946 · Cited by 67
Stegh, A. H., Chin, L., Louis, D. N., & DePinho, R. A. (2008) · Cell Cycle · doi:10.4161/cc.7.18.6759 · Cited by 57
Self-citationSita, T. L., Kouri, F. M., Hurley, L., Merkel, T. J., Chalastanis, A., May, J., Tommasini-Ghelfi, S., Cole, L. E., Cayton, T. C., Barnaby, S. N., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702736114 · Cited by 57
Self-citationCoelho, T., Adams, D., Conceição, I. M., Waddington‐Cruz, M., Schmidt, H., Buades, J., Campistol, J. M., Berk, J. L., Polydefkis, M. J., Wang, J. J., et al. (2020) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-020-01399-4 · Cited by 57
Toward personalized cancer nanomedicine – past, present, and future
Stegh, A. H. (2012) · Integrative Biology · doi:10.1039/c2ib20104f · Cited by 55
Self-citationKwon, S. M., Kang, S.-H., Park, C., Jung, S., Park, E. S., Lee, J., Kim, S.-H., & Woo, H. G. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140528 · Cited by 45
RNAi-mediated gene silencing in cancer therapy
Yang, W.-Q., & Zhang, Y. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.712107 · Cited by 34
X-Ray Fluorescence Microscopy for Investigation of Archival Tissues
Paunesku, T., Wanzer, M. B., Kirillova, E. N., Kn, M., Vs, R., Lyubchanskii, E. R., Grosche, B., Birschwilks, M., Vogt, S., Finney, L. A., et al. (2012) · Health Physics · doi:10.1097/hp.0b013e31824e7023 · Cited by 27
Self-citationGene Silencing Strategies in Cancer Therapy: An Update for Drug Resistance
Naghizadeh, S., Mansoori, B., Mohammadi, A., Sakhinia, E., & Baradaran, B. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180403141554 · Cited by 22
An update on RNA interference-mediated gene silencing in cancer therapy
Ren, Y., & Zhang, Y. (2014) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2014.935334 · Cited by 20
Refaat, T., West, D. L., Achy, S. E., Parimi, V., May, J., Xin, L., Harris, K. R., Liu, W., Wanzer, M. B., Finney, L. A., et al. (2016) · Nanomaterials · doi:10.3390/nano6080143 · Cited by 8
Self-citation
Cited by
Noncoding RNA therapeutics—Challenges and potential solutions
Winkle, M., El-Daly, S. M., Fabbri, M., & Calin, G. A. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00219-z · Cited by 1,551
Current advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Therapeutic siRNA: State-of-the-Art and Future Perspectives
Friedrich, M., & Aigner, A. (2022) · BioDrugs · doi:10.1007/s40259-022-00549-3 · Cited by 396
The Promise of Nanotechnology in Personalized Medicine
Alghamdi, M. A., Fallica, A. N., Virzì, N., Kesharwani, P., Pittalà, V., & Greish, K. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12050673 · Cited by 284
Glioblastoma Therapy: Past, Present and Future
Obrador, E., Moreno-Murciano, P., Oriol-Caballo, M., López-Blanch, R., Pineda, B., Gutiérrez-Arroyo, J., Loras, A., Gonzalez-Bonet, L., Martinez-Cadenas, C., Estrela, J., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052529 · Cited by 271
Metadata
- Authors
- Kumthekar, P., Ko, C. H., Paunesku, T., Dixit, K., Sonabend, A. M., Bloch, O., Tate, M., Schwartz, M., Zuckerman, L., Lezon, R., Lukas, R. V., Jovanovic, B., McCortney, K., Colman, H., Chen, S., Lai, B., Antipova, O., Deng, J., Li, L., Tommasini-Ghelfi, S., Hurley, L. A., Unruh, D., Sharma, N. V., Kandpal, M., Kouri, F. M., Davuluri, R. V., Brat, D. J., Muzzio, M., Glass, M., Vijayakumar, V., Heidel, J., Giles, F. J., Adams, A. K., James, C. D., Woloschak, G. E., Horbinski, C., & Stegh, A. H.
- Venue
- Science Translational Medicine
- Published
- 2021-03-10
- Volume
- 13
- Issue
- 584
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W3134295746
- Cited by
- 345
- References
- 59
- FWCI
- 13.62
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.